Recent Trends of Helicobacter pylori Eradication Therapy in Korea
The Korean Journal of Helicobacter and Upper Gastrointestinal Research
; : 219-223, 2012.
Article
en Ko
| WPRIM
| ID: wpr-134409
Biblioteca responsable:
WPRO
ABSTRACT
Helicobacter pylori infection is one of the most common gastrointestinal infectious diseases in Korea and is related to diseases such as gastritis, peptic ulcer disease, marginal zone B cell lymphoma of mucosa-associated lymphoid tissue type, and gastric adenocarcinoma. The eradication of H. pylori infection requires combinations of antibiotics and acid suppressants. Triple therapy has been considered as the first-line therapy for a long time. However, its eradication rate is declining and we need more effective strategies. Quadruple therapy including acid suppressants, bismuth, and other two antibiotics is a main rescue therapy after first-line therapy failure in Korea. In this review, we describe new therapeutic regimens and new trends of H. pylori eradication in Korea.
Palabras clave
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Úlcera Péptica
/
Bismuto
/
Adenocarcinoma
/
Enfermedades Transmisibles
/
Helicobacter pylori
/
Helicobacter
/
Linfoma de Células B de la Zona Marginal
/
Gastritis
/
Corea (Geográfico)
/
Tejido Linfoide
País/Región como asunto:
Asia
Idioma:
Ko
Revista:
The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Año:
2012
Tipo del documento:
Article